Table 3.
Clinical-pathological features | P | HR | 95% CI |
---|---|---|---|
Pathological N0/N2* Stages | 0.000 | 3.274 | 1.798–5.962 |
Histological type 1/2# | 0.046 | 2.142 | 1.015–4.519 |
ZG16 gene expression | 0.012 | 0.892 | 0.816–0.975 |
*N0/N2 indicate lymphatic metastasis in TNM stages; N0: tumor cells absent from regional lymph nodes; N2: tumor spread to an extent between N1 and N3. #1: adenocarcinoma; 2: mucinous adenocarcinoma